Compare GKOS & SIGI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | GKOS | SIGI |
|---|---|---|
| Founded | 1998 | 1926 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Property-Casualty Insurers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.0B | 5.2B |
| IPO Year | 2015 | N/A |
| Metric | GKOS | SIGI |
|---|---|---|
| Price | $100.96 | $74.00 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 14 | 5 |
| Target Price | ★ $133.07 | $84.40 |
| AVG Volume (30 Days) | ★ 577.7K | 400.6K |
| Earning Date | 04-29-2026 | 04-22-2026 |
| Dividend Yield | N/A | ★ 2.33% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $507,442,000.00 | N/A |
| Revenue This Year | $23.34 | $5.00 |
| Revenue Next Year | $27.46 | $4.87 |
| P/E Ratio | ★ N/A | $11.38 |
| Revenue Growth | ★ 32.33 | N/A |
| 52 Week Low | $73.16 | $71.75 |
| 52 Week High | $130.23 | $93.38 |
| Indicator | GKOS | SIGI |
|---|---|---|
| Relative Strength Index (RSI) | 37.84 | 22.95 |
| Support Level | $94.92 | $72.60 |
| Resistance Level | $104.66 | $80.39 |
| Average True Range (ATR) | 4.02 | 1.59 |
| MACD | -0.71 | -0.56 |
| Stochastic Oscillator | 22.45 | 10.79 |
Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases. It has commenced commercialization activities for iDose TR, a first-of-its-kind, long-duration, intracameral procedural pharmaceutical implant designed to continuously deliver glaucoma drug therapy inside the eye for extended periods of time. The company also offer commercially a proprietary bio-activated pharmaceutical therapy for the treatment of a rare corneal disorder, keratoconus. The company has three primary commercialized micro-scale surgical device products designed to treat glaucoma: the iStent, the iStent inject W, and the iStent infinite.
Selective Insurance Group Inc is a regional property-casualty insurer based in New Jersey, with its operations focused in the New York metropolitan area. The Company has four operating segments: Standard Commercial Lines, Standard Personal Lines, E&S Lines, and Investments. Majority of revenue is gained from Standard Commercial Lines segment, which comprises of property and casualty insurance products and services provided in the standard marketplace to commercial enterprises, which are typically businesses, non-profit organizations, and local government agencies.